Telescope Innovations Corp. (TELIF)
USD 0.23
(0.0%)
USD 0.23
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -356.8 Thousand CAD | 50.41% |
| 2022 | -719.49 Thousand CAD | 78.16% |
| 2021 | -3.29 Million CAD | -17888.27% |
| 2020 | 18.52 Thousand CAD | 0.0% |
| 2019 | 18.52 Thousand CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 1.61 Million CAD | 553.96% |
| 2023 FY | -356.8 Thousand CAD | 50.41% |
| 2023 Q3 | -275.79 Thousand CAD | 83.95% |
| 2023 Q2 | -1.71 Million CAD | -2.9% |
| 2023 Q4 | -356.8 Thousand CAD | -29.37% |
| 2023 Q1 | -1.67 Million CAD | -132.16% |
| 2022 Q3 | -510.63 Thousand CAD | 60.6% |
| 2022 FY | -719.49 Thousand CAD | 78.16% |
| 2022 Q4 | -719.49 Thousand CAD | -40.9% |
| 2022 Q2 | -1.29 Million CAD | 43.77% |
| 2022 Q1 | -2.3 Million CAD | 30.04% |
| 2021 Q3 | -4.32 Million CAD | -16347.2% |
| 2021 Q4 | -3.29 Million CAD | 23.84% |
| 2021 Q2 | 26.62 Thousand CAD | 2.48% |
| 2021 Q1 | 25.97 Thousand CAD | 1.66% |
| 2021 FY | -3.29 Million CAD | -17888.27% |
| 2020 FY | 18.52 Thousand CAD | 0.0% |
| 2020 Q4 | 25.55 Thousand CAD | 0.0% |
| 2019 FY | 18.52 Thousand CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 15.76 Million USD | 102.264% |
| Nanobac Pharmaceuticals, Incorporated | 4.11 Million USD | 108.665% |
| SQZ Biotechnologies Company | -36.23 Million USD | 99.015% |
| Evofem Biosciences, Inc. | 42.79 Million USD | 100.834% |
| Santhera Pharmaceuticals Holding AG | -6.3 Million USD | 94.34% |
| Mesoblast Limited | 55.85 Million USD | 100.639% |
| Propanc Biopharma, Inc. | 927.18 Thousand USD | 138.483% |
| Genus plc | 190.6 Million USD | 100.187% |
| VioQuest Pharmaceuticals, Inc. | 2.23 Million USD | 115.959% |
| CNBX Pharmaceuticals Inc. | 1.21 Million USD | 129.394% |
| Marizyme, Inc. | 18.56 Million USD | 101.922% |
| ContraFect Corporation | -6.02 Million USD | 94.079% |
| Nymox Pharmaceutical Corporation | 680 Thousand USD | 152.472% |
| PsyBio Therapeutics Corp. | 134.63 Thousand USD | 365.012% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.15 Million USD | 130.881% |
| Intellipharmaceutics International Inc. | 2.24 Million USD | 115.913% |
| AXIM Biotechnologies, Inc. | 5.5 Million USD | 106.485% |
| MultiCell Technologies, Inc. | 90.04 USD | 396378.321% |
| Accustem Sciences Inc. | -733.97 Thousand USD | 51.387% |
| RVL Pharmaceuticals plc | 12.94 Million USD | 102.756% |
| EV Biologics, Inc. | 1.36 Million USD | 126.083% |
| Q BioMed Inc. | 4.06 Million USD | 108.788% |
| Emmaus Life Sciences, Inc. | 30.55 Million USD | 101.168% |
| Neon Bloom, Inc. | 622.36 Thousand USD | 157.331% |
| Mosaic ImmunoEngineering Inc. | 1 Million USD | 135.408% |
| Biomind Labs Inc. | 711.4 Thousand USD | 150.156% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | 109.8 Million USD | 100.325% |
| Oncotelic Therapeutics, Inc. | 12.8 Million USD | 102.786% |
| Skye Bioscience, Inc. | -5.72 Million USD | 93.764% |
| Therapeutic Solutions International, Inc. | 860.24 Thousand USD | 141.478% |
| THC Farmaceuticals, Inc. | 139.8 Thousand USD | 355.221% |
| Arch Therapeutics, Inc. | 5.64 Million USD | 106.317% |
| IMV Inc. | 7.67 Million USD | 104.652% |
| Acro Biomedical Co., Ltd. | 19.86 Thousand USD | 1895.988% |
| Curative Biotechnology, Inc. | 2.2 Million USD | 116.204% |
| GB Sciences, Inc. | 1.74 Million USD | 120.42% |
| Alpha Cognition Inc. | -183.78 Thousand USD | -94.142% |
| HST Global, Inc. | 96.79 Thousand USD | 468.631% |
| CSL Limited | 10.52 Billion USD | 100.003% |
| Halberd Corporation | 144.72 Thousand USD | 346.55% |
| Enzolytics Inc. | 981.65 Thousand USD | 136.348% |
| Resverlogix Corp. | 6.45 Million USD | 105.531% |
| Affymax, Inc. | -5.59 Million USD | 93.625% |
| SYBLEU INC | 473.71 Thousand USD | 175.322% |
| Nuo Therapeutics, Inc. | -673.08 Thousand USD | 46.989% |
| argenx SE | -2.02 Billion USD | 99.982% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | 43.43 Million USD | 100.821% |
| Enzon Pharmaceuticals, Inc. | -47.01 Million USD | 99.241% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | 113.173% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -8.83 Million USD | 95.964% |
| AVAX Technologies, Inc. | -5.9 Million USD | 93.956% |
| Zenith Capital Corp. | 10.06 Thousand USD | 3645.399% |
| Genscript Biotech Corporation | -1.06 Billion USD | 99.966% |
| Ember Therapeutics, Inc. | 200.43 Thousand USD | 278.02% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | 2.38 Million USD | 114.954% |
| WPD Pharmaceuticals Inc. | 164.5 Thousand USD | 316.893% |
| American Oriental Bioengineering, Inc. | 60.54 Million USD | 100.589% |
| Provectus Biopharmaceuticals, Inc. | 1.99 Million USD | 117.846% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -2.57 Million USD | 86.117% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | 199.194% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | 20.27 Million USD | 101.76% |
| Cotinga Pharmaceuticals Inc. | -18.31 Thousand USD | -1847.86% |
| BioStem Technologies, Inc. | 4.47 Million USD | 107.979% |
| ONE Bio Corp. | 9.04 Million USD | 103.947% |
| Reve Technologies, Inc. | 201.25 Thousand USD | 277.293% |
| Burzynski Research Institute, Inc. | -1310.00 USD | -27137.328% |
| Wesana Health Holdings Inc. | 206.21 Thousand USD | 273.026% |
| Agentix Corp. | 37.63 Thousand USD | 1048.178% |
| LadRx Corporation | -2.03 Million USD | 82.479% |
| Cell Source, Inc. | 9.23 Million USD | 103.865% |
| ProtoKinetix, Incorporated | -20.4 Thousand USD | -1648.378% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | 156.176% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | 156.176% |
| NovAccess Global Inc. | 2.17 Million USD | 116.379% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | 105.046% |
| Itoco Inc. | 228.3 Thousand USD | 256.286% |
| Rasna Therapeutics, Inc. | 135.98 Thousand USD | 362.381% |
| Pathfinder Cell Therapy, Inc. | 4.95 Million USD | 107.198% |
| Kadimastem Ltd | -253.1 Thousand USD | -40.974% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | 188.792% |
| CytoDyn Inc. | 20.26 Million USD | 101.761% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -647.00 USD | -55048.223% |
| Mobile Lads Corp. | 484.23 Thousand USD | 173.686% |
| NanoSphere Health Sciences Inc. | -9268.34 USD | -3749.762% |
| Qrons Inc. | 351.42 Thousand USD | 201.531% |
| Alseres Pharmaceuticals, Inc. | 7.7 Million USD | 104.63% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -249.62 Thousand USD | -42.941% |
| Rebus Holdings, Inc. | 305 Thousand USD | 216.987% |
| ImmunoCellular Therapeutics, Ltd. | 4.45 Million USD | 108.006% |
| International Stem Cell Corporation | 2.59 Million USD | 113.776% |
| Bioxytran, Inc. | 1.89 Million USD | 118.79% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | 671.69% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | 116.361% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | 3.43 Million USD | 110.39% |
| Adhera Therapeutics, Inc. | 8.55 Million USD | 104.172% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | 772.6 Thousand USD | 146.182% |
| Innovation Pharmaceuticals Inc. | -1.25 Million USD | 71.455% |
| Neutra Corp. | 52.18 Thousand USD | 783.712% |
| Windtree Therapeutics, Inc. | -2.48 Million USD | 85.665% |
| PureTech Health plc | -167.19 Million USD | 99.787% |
| Coeptis Therapeutics, Inc. | -244.9 Thousand USD | -45.691% |
| IXICO plc | -4.44 Million USD | 91.972% |
| IntelGenx Technologies Corp. | 13.21 Million USD | 102.699% |
| Gelesis Holdings, Inc. | 54.85 Million USD | 100.651% |
| CSL Limited | 10.52 Billion USD | 100.003% |
| Cellectis S.A. | -43.81 Million USD | 99.186% |